Philippines - English - FDA (Food And Drug Administration)

dr. zen's research,inc./ lloyd lab. inc.; distributor: metz pharmaceuticals inc. - ceterizine dihydrochloride - oral solution - 1 mg / ml

Philippines - English - FDA (Food And Drug Administration)

jazmark pharmaceutical; distributor: jazmark pharmaceutical - levoceterizine hydrochloride - film-coated tablet - 5mg

Philippines - English - FDA (Food And Drug Administration)

rilem pharma corp. - ceterizine hydrochloride - oral solution - 1mg/ml

Philippines - English - FDA (Food And Drug Administration)

bridge marketing - levoceterizine hydrochloride - film-coated tablet - 5mg

Kenya - English - Pharmacy and Poisons Board

tempharma solutions ltd 19755 - 00202 nairobi - ceterizine dihydrochloride - film-coated tablet - 10mg - cetirizine

Malta - English - Medicines Authority

galpharm healthcare limited - cetirizine hydrochloride - film-coated tablet - cetirizine hydrochloride 10 milligram(s) - antihistamines for systemic use

Malta - English - Medicines Authority

chefaro ireland dac the sharp building, hogan place, dublin 2,, ireland - cetirizine hydrochloride - film-coated tablet - cetirizine hydrochloride 10 mg - antihistamines for systemic use

United States - English - NLM (National Library of Medicine)

dr.reddy's laboratories ltd. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride tablets are contraindicated in: - patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine , or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2) ]. - patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis. - pediatric patients 6 to 11 years of age with impaired renal function [see use in specific p

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - levocetirizine dihydrochloride - film coated tablet - 5 milligram - piperazine derivatives